Cargando…
A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement
X-linked hypohidrotic ectodermal dysplasia (XLHED), caused by a genetic deficiency of ectodysplasin A1 (EDA1), is a rare developmental disorder of ectodermal derivatives such as hair, sweat glands, and teeth. The absence of sweat glands and perspiration can evoke life-threatening hyperthermia. As mo...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138843/ https://www.ncbi.nlm.nih.gov/pubmed/37108325 http://dx.doi.org/10.3390/ijms24087155 |
_version_ | 1785032802947825664 |
---|---|
author | Schneider, Holm Schweikl, Christine Faschingbauer, Florian Hadj-Rabia, Smail Schneider, Pascal |
author_facet | Schneider, Holm Schweikl, Christine Faschingbauer, Florian Hadj-Rabia, Smail Schneider, Pascal |
author_sort | Schneider, Holm |
collection | PubMed |
description | X-linked hypohidrotic ectodermal dysplasia (XLHED), caused by a genetic deficiency of ectodysplasin A1 (EDA1), is a rare developmental disorder of ectodermal derivatives such as hair, sweat glands, and teeth. The absence of sweat glands and perspiration can evoke life-threatening hyperthermia. As molecular genetic findings are not always conclusive, the concentrations of circulating EDA1 may help to distinguish between total and partial EDA1 deficiencies. We previously treated nine male patients with obvious signs of XLHED with a recombinant EDA1 replacement protein, Fc-EDA, either shortly after birth (n = 3) or by prenatal administration in gestational week 26 and beyond (n = 6). Here, we present the long-term follow-up for up to six years. In patients who had received Fc-EDA after birth, neither sweat glands nor sweating ability were detected at the age of 12–60 months. In contrast, prenatal EDA1 replacement resulted in ample sweat gland development and pilocarpine-inducible sweating in all treated subjects, who also attained more permanent teeth than their untreated affected relatives. Normal perspiration has persisted for six years in the two oldest boys treated repeatedly with Fc-EDA in utero. When they had a sauna, adequate thermoregulation was evidenced. Lower sweat production after single prenatal dosing may indicate a dose–response relationship. The absence of circulating EDA1 in five prenatally treated subjects proved that these children would have been unable to perspire if they had been left untreated. The sixth infant was shown to produce an EDA1 molecule that, albeit interacting with its cognate receptor, cannot activate EDA1 signaling. In conclusion, a causal treatment of XLHED before birth is feasible. |
format | Online Article Text |
id | pubmed-10138843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-101388432023-04-28 A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement Schneider, Holm Schweikl, Christine Faschingbauer, Florian Hadj-Rabia, Smail Schneider, Pascal Int J Mol Sci Article X-linked hypohidrotic ectodermal dysplasia (XLHED), caused by a genetic deficiency of ectodysplasin A1 (EDA1), is a rare developmental disorder of ectodermal derivatives such as hair, sweat glands, and teeth. The absence of sweat glands and perspiration can evoke life-threatening hyperthermia. As molecular genetic findings are not always conclusive, the concentrations of circulating EDA1 may help to distinguish between total and partial EDA1 deficiencies. We previously treated nine male patients with obvious signs of XLHED with a recombinant EDA1 replacement protein, Fc-EDA, either shortly after birth (n = 3) or by prenatal administration in gestational week 26 and beyond (n = 6). Here, we present the long-term follow-up for up to six years. In patients who had received Fc-EDA after birth, neither sweat glands nor sweating ability were detected at the age of 12–60 months. In contrast, prenatal EDA1 replacement resulted in ample sweat gland development and pilocarpine-inducible sweating in all treated subjects, who also attained more permanent teeth than their untreated affected relatives. Normal perspiration has persisted for six years in the two oldest boys treated repeatedly with Fc-EDA in utero. When they had a sauna, adequate thermoregulation was evidenced. Lower sweat production after single prenatal dosing may indicate a dose–response relationship. The absence of circulating EDA1 in five prenatally treated subjects proved that these children would have been unable to perspire if they had been left untreated. The sixth infant was shown to produce an EDA1 molecule that, albeit interacting with its cognate receptor, cannot activate EDA1 signaling. In conclusion, a causal treatment of XLHED before birth is feasible. MDPI 2023-04-12 /pmc/articles/PMC10138843/ /pubmed/37108325 http://dx.doi.org/10.3390/ijms24087155 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Schneider, Holm Schweikl, Christine Faschingbauer, Florian Hadj-Rabia, Smail Schneider, Pascal A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement |
title | A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement |
title_full | A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement |
title_fullStr | A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement |
title_full_unstemmed | A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement |
title_short | A Causal Treatment for X-Linked Hypohidrotic Ectodermal Dysplasia: Long-Term Results of Short-Term Perinatal Ectodysplasin A1 Replacement |
title_sort | causal treatment for x-linked hypohidrotic ectodermal dysplasia: long-term results of short-term perinatal ectodysplasin a1 replacement |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138843/ https://www.ncbi.nlm.nih.gov/pubmed/37108325 http://dx.doi.org/10.3390/ijms24087155 |
work_keys_str_mv | AT schneiderholm acausaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT schweiklchristine acausaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT faschingbauerflorian acausaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT hadjrabiasmail acausaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT schneiderpascal acausaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT schneiderholm causaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT schweiklchristine causaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT faschingbauerflorian causaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT hadjrabiasmail causaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement AT schneiderpascal causaltreatmentforxlinkedhypohidroticectodermaldysplasialongtermresultsofshorttermperinatalectodysplasina1replacement |